- Title
- A new solid oral tablet formulation of posaconazole: a randomized clinical trial to investigate rising single- and multiple-dose pharmacokinetics and safety in healthy volunteers
- Creators
- G KRISHNA - Merck Sharp & Dohme Corp., Whitehouse Station, NJ, United StatesL MA - Merck Sharp & Dohme Corp., Whitehouse Station, NJ, United StatesM MARTINHO - Merck Sharp & Dohme Corp., Whitehouse Station, NJ, United StatesR. A PRESTON - Division of Clinical Pharmacology, Clinical Pharmacology Research Unit, University of Miami, Miami, FL, United StatesE O'MARA - Merck Sharp & Dohme Corp., Whitehouse Station, NJ, United States
- Publication Details
- Journal of antimicrobial chemotherapy, Vol.67(11), pp.2725-2730
- Publisher
- Oxford University Press; Oxford
- Academic Unit
- Miller School of Medicine; UMMG Dept of Medicine - Clinical Pharmacology
- Language
- English
- Resource Type
- Journal article
- PMID
- 22833639
- PMCID
- PMC3468079
- Record Identifier
- 991031575631502976
Journal article
A new solid oral tablet formulation of posaconazole: a randomized clinical trial to investigate rising single- and multiple-dose pharmacokinetics and safety in healthy volunteers
Journal of antimicrobial chemotherapy, Vol.67(11), pp.2725-2730
2012
PMCID: PMC3468079
PMID: 22833639
Metrics
9 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Industry collaboration
- Domestic collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.148 Medical Mycology
- 1.148.94 Candida Albicans
- Web Of Science research areas
- Infectious Diseases
- Microbiology
- Pharmacology & Pharmacy
- ESI research areas
- Pharmacology & Toxicology
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites